Bo-Seon Kim

Bo-Seon Kim

Auto-generated profile, based on publicly available information

Bo-Seon Kim

MediAge Research Center, Seongnam-si, Gyeonggi-do, Republic of South Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2023 in JMIR Formative Research
Verified
Journal Article
Open access
CBChulYoung Bae
ChulYoung Bae
BKBo-Seon Kim
Bo-Seon Kim
KCKyunghee Cho
Kyunghee Cho
JKJi-hyun Kim
Ji-hyun Kim
IKIn-Hee Kim
In-Hee Kim
JKJeong-Hoon Kim
Jeong-Hoon Kim
Background: Untact cultures have rapidly spread around the world as a result of the prolongation of the COVID-19 pandemic, leading to various types of research and technological developments in the fields of medicine and health care, where digital health care refers to health care services provided in a digital environment. Previous studies relating to digital health care demonstrated its effectiveness in managing chronic diseases such as hypertension and diabetes. While many studies have applied digital health care to various diseases, daily health care is needed for healthy individuals before they are diagnosed with a disease. Accordingly, research on individuals who have not been diagnosed with a disease is also necessary. Objective: This study aimed to identify the effects of using a customized digital health care service (CDHCS) on risk factors for metabolic syndrome (MS) and lifestyle improvement. Methods: The population consisted of 63 adults who underwent a health checkup at the National Health Insurance Service Ilsan (NHIS) Hospital in 2020. Measured variables include basic clinical indicators, MS-related variables, and lifestyle variables. All items were measured at NHIS Ilsan Hospital before the use of the CDHCS and 3 months thereafter. The CDHCS used in this study is a mobile app that analyzes the health condition of the user by identifying their risk factors and provides appropriate health care content. For comparison between before and after CDHCS use (pre-post comparison), paired t test was used for continuous variables, and a chi-square test was used for nominal variables. Results: The study population included 30 (47.6%) male and 33 (52.4%) female participants, and the mean age was 47.61 (SD 13.93) years. The changes in clinical indicators before and after intervention results showed a decrease in weight, waist circumference, triglyceride, and high-density lipoprotein cholesterol and increases in systolic blood pressure and diastolic blood pressure. The distribution of the risk group increased from 32 (50.8%) to 34 (54%) and that of the MS group decreased from 18 (28.6%) to 16 (25.4%). The mean metabolic syndrome age–chronological age before the CDHCS was 2.20 years, which decreased to 1.72 years after CDHCS, showing a decrease of 0.48 years in the mean metabolic syndrome age–chronological age after the intervention. While all lifestyle variables, except alcohol consumption, showed a tendency toward improvement, the differences were not statistically significant. Conclusions: Although there was no statistical significance in the variables under study, this pilot study will provide a foundation for more accurate verification of CDHCS in future research.

2 March 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CBChul-Young Bae
Chul-Young Bae
BKBo-Seon Kim
Bo-Seon Kim
KCKyung-Hee Cho
Kyung-Hee Cho
IKIn-Hee Kim
In-Hee Kim
JKJeong-Hoon Kim
Jeong-Hoon Kim
JKJi-Hyun Kim
Ji-Hyun Kim
The world is witnessing a sharp increase in its elderly population, accelerated by longer life expectancy and lower birth rates, which in turn imposes enormous medical burden on society. Although numerous studies have predicted medical expenses based on region, gender, and chronological age (CA), any attempt has rarely been made to utilize biological age (BA)—an indicator of health and aging—to ascertain and predict factors related to medical expenses and medical care use. Thus, this study employs BA to predict factors that affect medical expenses and medical care use. Referring to the health screening cohort database of the National Health Insurance Service (NHIS), this study targeted 276,723 adults who underwent health check-ups in 2009−2010 and kept track of the data on their medical expenses and medical care use up to 2019. The average follow-up period is 9.12 years. Twelve clinical indicators were used to measure BA, while the total annual medical expenses, total annual number of outpatient days, total annual number of days in hospital, and average annual increases in medical expenses were used as the variables for medical expenses and medical care use. For statistical analysis, this study employed Pearson correlation analysis and multiple regression analysis. Regression analysis of the differences between corrected biological age (cBA) and CA exhibited statistically significant increases (p<0.05) in all the variables of the total annual medical expenses, total annual number of outpatient days, total annual number of days in hospital, and average annual increases in medical expenses. This study quantified decreases in the variables for medical expenses and medical care use based on improved BA, thereby motivating people to become more health-conscious. In particular, this study is significant in that it is the first of its kind to predict medical expenses and medical care use through BA.

17 April 2026 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
PDF file
CBChul‐Young Bae
Chul‐Young Bae
BKBo‐Seon Kim
Bo‐Seon Kim
IKIn‐Hee Kim
In‐Hee Kim
MJMin‐Hee Jeon
Min‐Hee Jeon
Background: The prevalence of diabetes has been increasing, particularly among younger age groups with prolonged survival, and the risk of complications and the burden of healthcare costs are also expected to rise. We investigated the concept of biological age (BA) in patients with diabetes and there by developed a model to predict the risk and time of onset of diabetes complications. Methods: Using NHIS‐NHID data, we analysed 686,410 patients with diabetes who had undergone a health examination in 2009–2010. We analysed patients' data until 2020. We developed a BA model for patients with diabetes and predicted the risk of complications and the time of complication onset. Results: In both sexes, the incidences of all complications increased significantly with increasing corrected BA ( p < 0.05). Similarly, the time until onset of all complications decreased significantly with increasing corrected BA ( p < 0.05). Conclusions: Our study suggests that maintaining a lower BA is associated with a reduced risk of complications and a delayed onset of the disease, which may encourage diabetic patients to manage their health more effectively. This study is the first to apply the concept of BA, reflecting health and ageing status, to patients with diabetes to explore its relationship with the risk and timing of complications.

31 July 2022 in JMIR Preprints
Verified
Preprint
Open access
CBChul-Young Bae
Chul-Young Bae
BKBo-Seon Kim
Bo-Seon Kim
KCKyung-Hee Cho
Kyung-Hee Cho
JKJi-Hyun Kim
Ji-Hyun Kim
IKIn-Hee Kim
In-Hee Kim
JKJeong-Hoon Kim
Jeong-Hoon Kim
BACKGROUND Untact cultures have rapidly spread around the world as a result of the prolongation of the COVID-19 pandemic, leading to various types of research and technological developments in the fields of medicine and healthcare, where digital healthcare refers to healthcare services provided in a digital environment. OBJECTIVE This study aimed to identify the effects of using a customized digital healthcare service (CDHCS) on risk factors for metabolic syndrome (MS) and lifestyle improvement. METHODS The population consisted of 63 adults who underwent a health checkup at the National Health Insurance Service Ilsan Hospital in 2020. Measured variables include basic clinical indicators, MS-related variables, and lifestyle variables. The CDHCS used in this study is a mobile application that analyzes the health condition of the user by identifying their risk factors and provides appropriate healthcare content. RESULTS All measured variables, except drinking status, showed a tendency towards improvement, but the differences were not statistically significant. CONCLUSIONS Although there was no statistical significance in the variables under study, this pilot study will provide a foundation for more accurate verification of CDHCS in future research. CLINICALTRIAL All participants received verbal explanations regarding the study and submitted their prior written consent. This study was approved by the Institutional Review Board (IRB) of NHIS Ilsan Hospital (NHIMC 2020-02-002).

29 May 2026 in medRxiv
Verified
Preprint
Open access
PDF file
CBChul-Young Bae
Chul-Young Bae
BKBo-Seon Kim
Bo-Seon Kim
IKIn-Hee Kim
In-Hee Kim
YCYoon-Jin Choi
Yoon-Jin Choi
MJMin-Hee Jeon
Min-Hee Jeon
Background: With the rising prevalence of hypertension, especially among younger populations, there is a critical need to better assess health status and predict associated complications. This study developed a biological age model (“hypertension age”) for hypertensive patients to predict the risk and timing of major complications. Methods: Using South Korea’s NHIS-NHID data, researchers analyzed 4,535,041 hypertensive patients who underwent health examinations between 2009 and 2010. Patients were followed for an average of 12.40 years (until 2022). Principal Component Analysis (PCA) was used to develop the biological age (cBA) model. The risk and onset timing of complications were analyzed using Cox proportional hazards and multiple regression models, adjusting for variables like medication use and baseline diseases. Results: A 1-standard deviation (SD) increase in the age gap—where biological age exceeds chronological age (cBA - CA)—was significantly associated with an elevated risk for all major complications in both sexes (p < 0.001). Furthermore, a 1-SD increase in this gap significantly accelerated the time to complication onset for nearly all conditions (p < 0.001), with the exception of dementia in women. The impacts of medication use, hypertension duration, and baseline comorbidities varied by specific complication. Conclusions: Lowering “hypertension age” relative to chronological age can significantly reduce the risk and delay the onset of major cardiovascular and related complications. Quantifying this biological age gap serves as a powerful motivational tool for personalized health management and complication prevention in hypertensive patients. Novelty and Relevance: What Is New? This study is the first to develop a novel “hypertension age” biological model using a massive, real-world database of over 4.5 million patients followed for 12.4 years to uniquely predict both the exact risk and the specific timing of multi-organ complications. What Is Relevant? This research directly addresses the rising global burden of hypertension by demonstrating that a 1-SD increase in the biological-chronological age gap significantly accelerates the onset of major cardiovascular and systemic complications. Clinical/Pathophysiological Implications? These findings shift clinical focus from strict blood pressure thresholds to holistic biological aging, providing an intuitive, metrics-driven communication tool to enhance patient compliance and personalized risk management.